查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2100476

主動脈血管支架市場：全球市場預測，2026-2032年

Aortic Stent Grafts Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，主動脈血管支架市場將成長至 21.3 億美元，複合年成長率為 7.73%。

主要市場統計數據
基準年 2025 12.6億美元
預計年份：2026年 13.5億美元
預測年份 2032 21.3億美元
複合年成長率 (%) 7.73%

主動脈血管支架是一種用於治療胸腹腹部主動脈血管瘤、主動脈剝離、創傷性主動脈損傷以及某些穿孔性潰瘍的血管內植入式醫療設備。其治療原理是透過加強主動脈病變部位並阻斷來自薄弱血管壁的血流。由於心血管疾病、人口老化、高血壓、吸菸相關血管疾病以及影像技術的進步等因素導致的主動脈疾病檢出率不斷提高，其臨床意義日益凸顯。與開放性手術相比，血管內動脈瘤修復術可以減輕手術全期負擔，縮短恢復時間，並為那些被認為不適合傳統手術的高風險患者提供更多治療選擇。然而，該手術需要嚴格的解剖學規劃、器械選擇、影像學後續觀察以及對內漏、移位、骶骨行為和分支血管通暢性的長期監測。

目前，主動脈血管支架的發展特徵是輸送系統、移植物材料、密封機制、開窗和分叉結構以及術中成像等方面的持續創新。市場需求受到以下因素的影響：需要更小巧的裝置、對複雜解剖結構的更高適應性、在頸部和彎曲的髂動脈通路中改善治療效果，以及解決主動脈弓、胸腹部和腎旁區域病變的方案。醫療系統也強調實證患者選擇、持續的臨床療效、輻射劑量管理以及標準化的術後隨訪，以最佳化安全性和資源利用。

主動脈血管支架領域的變革性變化

主動脈血管支架產業正從標準的動脈瘤閉塞療法轉向以患者為中心、解剖結構適應性強的血管內治療。這種向開窗式、分支式和醫生客製化方案的轉變，反映了臨床上日益成長的治療複雜主動脈疾病（包括內臟、腎動脈、髂動脈和主動脈弓分支血管​​）的需求。電腦血管造影術（CTA）、3D重建、血管內成像、融合引導和手術模擬等技術的進步，為這一轉變提供了支持，使得支架的尺寸選擇、定位和植入更加精準。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過影像分析、工作流程最佳化、裝置規劃和後續觀察，對主動脈血管支架移植生態系統產生日益顯著的影響。 AI 驅動的 CT血管攝影檢查分割技術可幫助臨床醫生測量動脈瘤直徑、瘤頸長度、角度、血栓體積、鈣化程度、髂動脈路徑以及分支血管方向。這些功能降低了手動測量帶來的誤差，並支持更一致的術前規劃，尤其是在複雜的血管內動脈瘤修復術和胸主動脈血管內修復術。

關於主動脈血管支架的關鍵區域見解

在亞太地區，隨著主要城市醫療體系內三級醫院、先進影像中心和血管外科手術能力的提升，主動脈血管支架手術的普及程度正在提高。日本、韓國、澳洲、中國和印度是重要的臨床應用地區，這主要歸因於人口老化、動脈瘤疾病檢出率的提高以及微創介入心臟病學治療的日益普及。儘管保險報銷制度的差異、大都會圈以外地區醫療資源的匱乏以及專業培訓的需求仍然是重要的考慮因素，但局部解剖結構的差異和不斷成長的手術量仍然影響著血管內動脈瘤修復術和胸主動脈血管內修復術中器械的選擇。

主動脈血管支架的關鍵組分析

東南亞國協正透過三級醫院現代化、擴大私立醫療網路以及在主要醫療中心推廣影像引導心血管手術，來增強其提供主動脈血管支架的能力。各成員國之間的醫療服務可近性差異顯著，手術可行性取決於專科醫生的訓練水準、保險報銷情況以及進口醫療設備的供應情況。在海灣合作理事會（GCC）國家，積極投資於先進的醫院基礎設施、建立國際臨床合作關係以及政府主導的擴大心血管專科護理的舉措，已被證明能夠有效促進主要轉診機構開展血管內修復術。

各國主動脈血管支架的關鍵見解

在美國，主動脈血管支架應用廣泛，這得益於先進的血管中心、複合手術室、多學科主動脈項目，以及對監管證據、臨床結果和後續觀察的高度重視。在加拿大，高品質的血管內治療在公共醫療體系內可獲得，其可近性受省級醫保報銷方案、轉診途徑以及複雜手術集中於專科中心的影響。在墨西哥，私立醫院和大型公立醫療機構正在擴大治療範圍，但先進移植物配置的可及性因地區和支付方而異。巴西仍然是拉丁美洲血管內主動脈修復的領先中心，這得益於大都會圈心血管醫學方面的專業知識，但醫療保險報銷方案和公共部門採購正在影響更廣泛的患者群體。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的創新技術，這些技術需能應對複雜的解剖結構、確保長期耐久性和提高手術效率。研發工作應著重於具有低輪廓輸送系統、更佳貼合度、更先進的密封技術、保留分支血管的設計以及抗疲勞性能的移植物材料。證據的取得應包括長期追蹤研究、真實世界臨床註冊研究、解剖結構複雜病例的次族群分析，以及對諸如內漏、再次手術、囊腫消退和存活率等結果的標準化報告。

獲取實證見解的調查方法

評估主動脈血管支架現況的可靠調查方法需要結合二手資料研究、一手檢驗和結構化分析綜述。二手資料研究應包括同行評審的臨床文獻、監管資料庫、血管外科指南、臨床試驗註冊庫、醫院採購資訊、公共衛生資料、醫療設備安全資訊以及專業學會出版刊物。一手驗證研究應邀請血管外科醫師、介入性放射科醫師、心胸外科醫師、醫院管理人員、採購負責人、影像專家以及保險報銷相關人員參與，以檢驗臨床應用模式、未滿足的需求、訓練缺口以及區域可近性趨勢。

結論

主動脈血管支架在主動脈疾病治療的現代化過程中發揮核心作用，它使腹主動脈和胸主動脈疾病患者能夠接受微創治療，同時拓展了先進影像技術、專業手術規劃和長期後續觀察的應用範圍。該行業的發展受到許多因素的影響，包括應對複雜的解剖結構、人工智慧驅動的工作流程、更嚴格的證據要求以及在醫療服務取得、報銷和臨床基礎設施方面的區域差異。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 主動脈血管支架市場：依移植物類型分類

  • 分支支架血管支架
  • 帶開窗的血管支架
  • 標準血管支架

第8章：主動脈血管支架市場：依配置分類

  • 主動脈和單側髂骨
  • 分支類型
  • 袖口

第9章：主動脈血管支架市場：依動脈瘤位置分類

  • 腹部主動脈血管瘤
  • 胸主動脈瘤
  • 胸腹腹部主動脈血管瘤

第10章：主動脈血管支架市場：依置入機制分類

  • 球囊擴張型
  • 自膨脹

第11章 主動脈血管支架市場：以入路方式分類

  • 髂骨
  • 經股動脈

第12章 主動脈血管支架市場：依材料分類

  • 膨體聚四氟乙烯
  • 聚酯纖維

第13章 主動脈血管支架市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第14章 主動脈血管支架市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第15章 主動脈血管支架市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第16章 主動脈血管支架市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Aortec Medical Technology Co., Ltd
  • Artivion, Inc.
  • Bentley InnoMed GmbH
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cordis Corp.
  • Endologix, Inc.
  • Endospan Ltd
  • Japan Lifeline Co., Ltd.
  • LifeTech Scientific Corporation
  • Lombard Medical Ltd
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Phenox
  • Relisys Medical Devices Limited
  • Terumo Corporation
  • Vascumed（Pty）Ltd
  • WL Gore & Associates, Inc.
Product Code: MRR-B168537782D2

The Aortic Stent Grafts Market is projected to grow by USD 2.13 billion at a CAGR of 7.73% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.26 billion
Estimated Year [2026] USD 1.35 billion
Forecast Year [2032] USD 2.13 billion
CAGR (%) 7.73%

Aortic stent grafts are endovascular implantable devices used to treat thoracic and abdominal aortic aneurysms, dissections, traumatic aortic injury, and selected penetrating ulcers by reinforcing the diseased aortic segment and excluding blood flow from the weakened vessel wall. Their clinical relevance is rising as cardiovascular disease, population aging, hypertension, smoking-related vascular damage, and improved diagnostic imaging increase the detection of aortic pathology. Compared with open surgical repair, endovascular aneurysm repair can reduce perioperative trauma, shorten recovery time, and expand treatment options for patients considered high risk for conventional surgery, while requiring rigorous anatomical planning, device selection, imaging follow-up, and long-term surveillance for endoleak, migration, sac behavior, and branch vessel patency.

The aortic stent graft landscape is defined by continuous innovation in delivery systems, graft materials, sealing mechanisms, fenestrated and branched configurations, and procedural imaging. Demand is shaped by the need for lower-profile devices, greater conformability in complex anatomies, improved outcomes in hostile necks and tortuous iliac access, and solutions that address arch, thoracoabdominal, and juxtarenal disease. Healthcare systems are also emphasizing evidence-based patient selection, durable clinical outcomes, radiation dose management, and standardized post-procedure follow-up to optimize safety and resource use.

Transformative Shifts in the Aortic Stent Graft Landscape

The aortic stent graft industry is shifting from standard aneurysm exclusion toward patient-specific, anatomy-adapted endovascular therapy. The movement toward fenestrated, branched, and physician-modified approaches reflects the growing clinical need to manage complex aortic disease involving visceral, renal, iliac, and arch branch vessels. This evolution is supported by advances in computed tomography angiography, three-dimensional reconstruction, intravascular imaging, fusion guidance, and procedural simulation, enabling more precise sizing, alignment, and deployment.

Regulatory and clinical expectations are also transforming the landscape. Long-term device durability, real-world evidence, post-market surveillance, and standardized reporting of complications are becoming more important as endovascular repair is used across broader patient groups. Hospitals are investing in hybrid operating rooms, vascular imaging infrastructure, multidisciplinary aortic teams, and protocolized surveillance pathways. At the same time, reimbursement scrutiny and value-based care are encouraging decision-makers to evaluate not only procedural success but also reintervention rates, length of stay, follow-up burden, and patient quality of life. These shifts are driving manufacturers, clinicians, and health systems to prioritize devices and workflows that deliver durable sealing, accurate positioning, reduced access complications, and predictable long-term performance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing the aortic stent graft ecosystem through image analysis, workflow optimization, device planning, and longitudinal surveillance. AI-enabled segmentation of computed tomography angiography can assist clinicians in measuring aneurysm diameter, neck length, angulation, thrombus burden, calcification, iliac access, and branch vessel orientation. These capabilities can reduce manual measurement variability and support more consistent preoperative planning, particularly for complex endovascular aneurysm repair and thoracic endovascular aortic repair.

In procedure planning, AI-supported three-dimensional modeling and automated centerline analysis can help identify anatomical suitability, predict landing zones, and flag features associated with endoleak, limb occlusion, or access difficulty. In follow-up care, machine learning tools can support detection of sac expansion, device migration, graft kinking, and endoleaks across serial imaging studies, enabling earlier review by vascular specialists. AI also has operational relevance by improving case scheduling, inventory planning, radiation dose tracking, and clinical documentation. However, adoption depends on validated algorithms, transparent performance metrics, cybersecurity, interoperability with imaging systems, clinician oversight, and compliance with medical device software regulations. The cumulative impact of artificial intelligence is therefore not device replacement but decision augmentation, helping clinicians improve consistency, efficiency, and surveillance quality across the aortic repair pathway.

Key Regional Insights for Aortic Stent Grafts

Asia-Pacific is experiencing expanding access to aortic stent graft procedures as tertiary hospitals, advanced imaging centers, and vascular surgery capabilities develop across major urban healthcare systems. Japan, South Korea, Australia, China, and India are important clinical environments due to aging populations, increased detection of aneurysmal disease, and growing use of minimally invasive cardiovascular interventions. Reimbursement variability, uneven access outside metropolitan centers, and the need for specialized training remain key considerations, while local anatomical diversity and rising procedural volumes continue to shape device preferences for endovascular aneurysm repair and thoracic endovascular aortic repair.

North America is characterized by mature endovascular infrastructure, widespread computed tomography angiography use, established vascular surgery and interventional radiology expertise, and strong emphasis on clinical evidence, post-market surveillance, and guideline-based care. The United States and Canada continue to prioritize patient selection, long-term follow-up, and advanced solutions for complex thoracic and abdominal aortic disease. Latin America is advancing through public and private hospital investment, with Brazil and Mexico serving as important centers for cardiovascular intervention; however, procurement constraints, reimbursement fragmentation, and regional disparities influence access to advanced graft systems.

Europe combines strong vascular clinical networks, structured regulatory oversight, and high adoption of endovascular approaches across countries with advanced hospital systems. Germany, France, Italy, Spain, and the United Kingdom show sustained emphasis on hybrid operating facilities, registries, and complex aortic repair programs, while broader regional differences remain tied to healthcare funding and device access. The Middle East is led by specialized cardiovascular centers in high-income countries that are investing in advanced endovascular technologies, while broader regional adoption depends on specialist availability and referral pathways. Africa presents a more uneven landscape, with growth concentrated in select urban centers where imaging, vascular expertise, and endovascular suites are available; broader access is limited by infrastructure, affordability, and workforce constraints.

Key Group Insights for Aortic Stent Grafts

ASEAN countries are strengthening aortic stent graft capabilities through modernization of tertiary hospitals, expansion of private healthcare networks, and increasing adoption of image-guided cardiovascular procedures in major medical hubs. Access varies significantly across member states, with procedural availability influenced by specialist training, reimbursement, and imported device procurement. GCC countries benefit from strong investment in advanced hospital infrastructure, international clinical partnerships, and government-led initiatives to expand specialized cardiovascular care, supporting adoption of endovascular repair in leading referral centers.

The European Union provides a highly regulated and clinically sophisticated environment for aortic stent grafts, with emphasis on device safety, clinical evidence, traceability, and post-market performance monitoring under evolving medical device regulation. Cross-country differences in reimbursement and procurement practices influence adoption timing, but the region remains important for complex aortic intervention, registries, and structured surveillance. BRICS countries represent a diverse group in which China, India, and Brazil are expanding endovascular capacity through healthcare infrastructure growth and rising specialist expertise, while Russia and South Africa demonstrate more concentrated access in major centers. Across BRICS, affordability, public hospital budgets, and local manufacturing or procurement policy can shape availability.

G7 countries collectively represent advanced clinical ecosystems with established vascular surgery programs, sophisticated imaging, and high expectations for long-term clinical data. These countries typically support complex endovascular techniques, multidisciplinary aortic teams, and ongoing surveillance protocols. NATO member countries overlap substantially with advanced North American and European systems, where defense and trauma-related vascular expertise, emergency care networks, and cardiovascular infrastructure can support thoracic endovascular applications, including traumatic aortic injury. Across all groups, the most important differentiators are clinical training, imaging capacity, reimbursement clarity, and adherence to evidence-based follow-up.

Key Country Insights for Aortic Stent Grafts

The United States has extensive aortic stent graft adoption supported by advanced vascular centers, hybrid operating rooms, multidisciplinary aortic programs, and a strong focus on regulatory evidence, real-world outcomes, and post-procedure surveillance. Canada demonstrates high-quality endovascular care within a publicly funded system, with access shaped by provincial reimbursement, referral pathways, and concentration of complex procedures in specialized centers. Mexico is expanding access through private hospitals and major public institutions, although availability of advanced graft configurations varies by region and payer type. Brazil remains a major Latin American hub for endovascular aortic repair, supported by cardiovascular expertise in large urban centers, while reimbursement and public-sector procurement affect broader access.

In Europe, the United Kingdom emphasizes guideline-driven vascular care, centralized complex aortic services, and outcome monitoring. Germany benefits from a dense network of advanced hospitals and high procedural specialization, particularly in complex aortic repair. France combines strong clinical expertise with structured health technology assessment and reimbursement pathways. Russia has significant specialist capability in leading urban institutions, though access can vary across geography. Italy and Spain maintain well-established vascular surgery and interventional programs, with adoption influenced by regional healthcare organization, hospital budgets, and specialist availability.

In Asia-Pacific, China is expanding endovascular aortic capabilities through hospital modernization, increasing imaging utilization, and specialist training in major cities. India shows rising adoption in advanced cardiac and vascular centers, supported by a growing burden of cardiovascular disease and broader access to diagnostic imaging, while affordability remains an important factor. Japan has a highly developed endovascular environment shaped by population aging, advanced imaging, and clinical attention to device durability. Australia offers strong access in specialized centers, supported by structured healthcare delivery and vascular expertise. South Korea combines advanced hospital technology, high imaging capacity, and strong procedural specialization, enabling uptake of sophisticated aortic stent graft techniques.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated innovation that addresses complex anatomy, long-term durability, and procedural efficiency. Development efforts should focus on lower-profile delivery systems, improved conformability, enhanced sealing technologies, branch-preserving designs, and graft materials with proven fatigue resistance. Evidence generation should include long-term follow-up, real-world registries, subgroup analysis for challenging anatomy, and standardized reporting of endoleak, reintervention, sac regression, and survival outcomes.

Commercial and clinical strategies should be aligned with regional healthcare realities. In mature markets, leaders should strengthen physician education for complex endovascular repair, integrate AI-enabled planning tools, support surveillance workflows, and demonstrate value through reduced complications and reinterventions. In emerging markets, success depends on training programs, partnerships with referral centers, reimbursement engagement, and adaptable product portfolios that match infrastructure and affordability constraints. Across all regions, organizations should enhance supply reliability, maintain regulatory readiness, invest in post-market surveillance, and collaborate with clinicians to improve patient selection, procedural planning, and follow-up adherence.

Research Methodology for Evidence-Based Insights

A robust research methodology for evaluating the aortic stent graft landscape should combine secondary research, primary validation, and structured analytical review. Secondary research includes peer-reviewed clinical literature, regulatory databases, vascular surgery guidelines, clinical trial registries, hospital procurement information, public health data, device safety communications, and professional society publications. Primary research should involve vascular surgeons, interventional radiologists, cardiothoracic surgeons, hospital administrators, procurement specialists, imaging experts, and reimbursement stakeholders to validate clinical adoption patterns, unmet needs, training gaps, and regional access dynamics.

The analysis should segment insights by application, anatomy, device type, end-user setting, procedural workflow, and geography while avoiding unsupported assumptions. Data triangulation should be used to compare clinical evidence, expert perspectives, regulatory activity, and healthcare infrastructure indicators. Quality controls should include source verification, exclusion of unverifiable claims, consistency checks across regions, and review of terminology related to endovascular aneurysm repair, thoracic endovascular aortic repair, fenestrated and branched endografts, and complex aortic intervention. This methodology ensures that conclusions are evidence-based, transparent, and relevant to strategic decision-making without relying on speculative sizing or forecasting.

Conclusion

Aortic stent grafts are central to the modernization of aortic disease management, enabling less invasive treatment for patients with abdominal and thoracic aortic pathology while expanding the role of advanced imaging, specialized procedural planning, and long-term surveillance. The industry is being shaped by complex anatomy solutions, AI-assisted workflows, stronger evidence requirements, and regional differences in access, reimbursement, and clinical infrastructure.

Future competitiveness will depend on proven clinical durability, physician confidence, regulatory compliance, and the ability to support complete care pathways from diagnosis and planning to implantation and follow-up. Stakeholders that combine device innovation with training, data transparency, AI-enabled decision support, and region-specific access strategies will be best positioned to meet the evolving needs of vascular specialists and patients requiring endovascular aortic repair.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Aortic Stent Grafts Market, by Graft Type

  • 7.1. Introduction
  • 7.2. Branched Stent Graft
  • 7.3. Fenestrated Stent Graft
  • 7.4. Standard Stent Graft

8. Aortic Stent Grafts Market, by Configuration

  • 8.1. Introduction
  • 8.2. Aorto-Uni-Iliac
  • 8.3. Bifurcated
  • 8.4. Cuff

9. Aortic Stent Grafts Market, by Aneurysm Location

  • 9.1. Introduction
  • 9.2. Abdominal Aortic Aneurysm
  • 9.3. Thoracic Aortic Aneurysm
  • 9.4. Thoracoabdominal Aortic Aneurysm

10. Aortic Stent Grafts Market, by Deployment Mechanism

  • 10.1. Introduction
  • 10.2. Balloon Expandable
  • 10.3. Self Expanding

11. Aortic Stent Grafts Market, by Access Route

  • 11.1. Introduction
  • 11.2. Iliac
  • 11.3. Transfemoral

12. Aortic Stent Grafts Market, by Material

  • 12.1. Introduction
  • 12.2. Expanded Polytetrafluoroethylene
  • 12.3. Polyester

13. Aortic Stent Grafts Market, by End User

  • 13.1. Introduction
  • 13.2. Ambulatory Surgical Centers
  • 13.3. Hospitals

14. Aortic Stent Grafts Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. Europe
  • 14.3. North America
  • 14.4. Latin America
  • 14.5. Africa
  • 14.6. Middle East

15. Aortic Stent Grafts Market, by Group

  • 15.1. NATO
  • 15.2. G7
  • 15.3. BRICS
  • 15.4. European Union
  • 15.5. ASEAN
  • 15.6. GCC

16. Aortic Stent Grafts Market, by Country

  • 16.1. China
  • 16.2. United States
  • 16.3. Japan
  • 16.4. India
  • 16.5. Germany
  • 16.6. United Kingdom
  • 16.7. Australia
  • 16.8. France
  • 16.9. South Korea
  • 16.10. Italy
  • 16.11. Canada
  • 16.12. Russia
  • 16.13. Brazil
  • 16.14. Mexico
  • 16.15. Spain

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Aortec Medical Technology Co., Ltd
  • 18.2. Artivion, Inc.
  • 18.3. Bentley InnoMed GmbH
  • 18.4. Cardinal Health, Inc.
  • 18.5. Cook Medical LLC
  • 18.6. Cordis Corp.
  • 18.7. Endologix, Inc.
  • 18.8. Endospan Ltd
  • 18.9. Japan Lifeline Co., Ltd.
  • 18.10. LifeTech Scientific Corporation
  • 18.11. Lombard Medical Ltd
  • 18.12. Medtronic plc
  • 18.13. MicroPort Scientific Corporation
  • 18.14. Phenox
  • 18.15. Relisys Medical Devices Limited
  • 18.16. Terumo Corporation
  • 18.17. Vascumed (Pty) Ltd
  • 18.18. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AORTIC STENT GRAFTS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL AORTIC STENT GRAFTS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL AORTIC STENT GRAFTS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL AORTIC STENT GRAFTS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL AORTIC STENT GRAFTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL AORTIC STENT GRAFTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL AORTIC STENT GRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRANCHED STENT GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRANCHED STENT GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRANCHED STENT GRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FENESTRATED STENT GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FENESTRATED STENT GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FENESTRATED STENT GRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STANDARD STENT GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STANDARD STENT GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STANDARD STENT GRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AORTO-UNI-ILIAC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AORTO-UNI-ILIAC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AORTO-UNI-ILIAC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIFURCATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIFURCATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIFURCATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CUFF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CUFF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CUFF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ABDOMINAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ABDOMINAL AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ABDOMINAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL THORACIC AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL THORACIC AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL THORACIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL THORACOABDOMINAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL THORACOABDOMINAL AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL THORACOABDOMINAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BALLOON EXPANDABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BALLOON EXPANDABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BALLOON EXPANDABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SELF EXPANDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SELF EXPANDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SELF EXPANDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ILIAC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ILIAC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ILIAC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TRANSFEMORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRANSFEMORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TRANSFEMORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXPANDED POLYTETRAFLUOROETHYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXPANDED POLYTETRAFLUOROETHYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXPANDED POLYTETRAFLUOROETHYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POLYESTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POLYESTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POLYESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. NATO AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. NATO AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NATO AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 114. NATO AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 115. NATO AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 116. NATO AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 117. NATO AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. NATO AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. G7 AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. G7 AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. G7 AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 122. G7 AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 123. G7 AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 124. G7 AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 125. G7 AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. G7 AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. GCC AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GCC AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 154. GCC AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 156. GCC AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. JAPAN AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. JAPAN AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. JAPAN AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 179. JAPAN AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 180. JAPAN AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 181. JAPAN AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 182. JAPAN AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. JAPAN AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. INDIA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. INDIA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. INDIA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 187. INDIA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 188. INDIA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 189. INDIA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 190. INDIA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. INDIA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GERMANY AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. GERMANY AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. GERMANY AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 195. GERMANY AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 196. GERMANY AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 197. GERMANY AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 198. GERMANY AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. GERMANY AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED KINGDOM AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED KINGDOM AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED KINGDOM AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED KINGDOM AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED KINGDOM AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED KINGDOM AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED KINGDOM AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED KINGDOM AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. AUSTRALIA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. AUSTRALIA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. AUSTRALIA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 211. AUSTRALIA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 212. AUSTRALIA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 213. AUSTRALIA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 214. AUSTRALIA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 215. AUSTRALIA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. FRANCE AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. FRANCE AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. FRANCE AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 219. FRANCE AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 220. FRANCE AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 221. FRANCE AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 222. FRANCE AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. FRANCE AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. SOUTH KOREA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. SOUTH KOREA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. SOUTH KOREA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 227. SOUTH KOREA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 228. SOUTH KOREA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 229. SOUTH KOREA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 230. SOUTH KOREA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 231. SOUTH KOREA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ITALY AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. ITALY AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. ITALY AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 235. ITALY AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 236. ITALY AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 237. ITALY AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 238. ITALY AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. ITALY AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. RUSSIA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. RUSSIA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 252. RUSSIA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 253. RUSSIA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 254. RUSSIA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 255. RUSSIA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 262. BRAZIL AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. SPAIN AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. SPAIN AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. SPAIN AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 275. SPAIN AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 276. SPAIN AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 277. SPAIN AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 278. SPAIN AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 279. SPAIN AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. GLOBAL AORTIC STENT GRAFTS MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 281. GLOBAL AORTIC STENT GRAFTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025